Modeling cellular response in large-scale radiogenomic databases to advance precision radiotherapy

Radiotherapy is integral to the care of a majority of cancer patients. Despite differences in tumor responses to radiation (radioresponse), dose prescriptions are not currently tailored to individual patients. Recent large-scale cancer cell line databases hold the promise of unravelling the complex molecular arrangements underlying cellular response to radiation, which is critical to novel predictive biomarker discovery. Here, we present RadioGx, a computational platform for integrative analyses of radioresponse using radiogenomic databases. We first used RadioGx to investigate the robustness of radioresponse assays and indicators. We then combined radioresponse and genome-wide molecular data with established radiobiological models to predict molecular pathways that are relevant for individual tissue types and conditions. We also applied RadioGx to pharmacogenomic data to identify several classes of drugs whose effects correlate with radioresponse. RadioGx provides a unique computational toolbox to advance preclinical research for radiation oncology and precision medicine.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  Crispin J. Miller,et al.  Investigation of Radiosensitivity Gene Signatures in Cancer Cell Lines , 2014, PloS one.

[3]  I. Nookaew,et al.  Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods , 2013, Nucleic acids research.

[4]  Dirk Verellen,et al.  Innovations in image-guided radiotherapy , 2008, Nature Reviews Cancer.

[5]  Anton Nekrutenko,et al.  Ten Simple Rules for Reproducible Computational Research , 2013, PLoS Comput. Biol..

[6]  J. Fowler.  The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.

[7]  S. Biswal,et al.  Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. , 2010, Antioxidants & redox signaling.

[8]  Robert Jeraj,et al.  An imaging-based tumour growth and treatment response model: investigating the effect of tumour oxygenation on radiation therapy response , 2008, Physics in medicine and biology.

[9]  Andrew H. Beck,et al.  PharmacoGx: an R package for analysis of large pharmacogenomic datasets , 2015, Bioinform..

[10]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[11]  G. Steel,et al.  The radioresponsiveness of human tumours and the initial slope of the cell survival curve. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  J. Torres-Roca,et al.  Predicting response to clinical radiotherapy: past, present, and future directions. , 2008, Cancer control : journal of the Moffitt Cancer Center.

[13]  Steven Eschrich,et al.  Prediction of radiation sensitivity using a gene expression classifier. , 2005, Cancer research.

[14]  E. Hall,et al.  Radiation oncology: a century of achievements , 2004, Nature Reviews Cancer.

[15]  Drew J. Adams,et al.  Radiotherapy in the Era of Precision Medicine. , 2015, Seminars in radiation oncology.

[16]  Mikael Karlsson,et al.  The effects of hypoxia on the theoretical modelling of tumour control probability , 2005, Acta oncologica.

[17]  M. Krause,et al.  Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: Differences between antibodies and TK inhibitors , 2009, International journal of radiation biology.

[18]  Bentzen,et al.  Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury. , 1994, Seminars in radiation oncology.

[19]  L. Wessels,et al.  Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients , 2015, Clinical Cancer Research.

[20]  Jean-Emmanuel Bibault,et al.  Personalized radiation therapy and biomarker-driven treatment strategies: a systematic review , 2013, Cancer and Metastasis Reviews.

[21]  L. Skarsgard,et al.  Dose dependence of the oxygen enhancement ratio (OER) in radiation inactivation of Chinese hamster V79-171 cells. , 1991, Radiation Research.

[22]  Joshua A. Bittker,et al.  Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset. , 2015, Cancer discovery.

[23]  R G Dale,et al.  The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. , 1985, The British journal of radiology.

[24]  J. Sarkaria,et al.  Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology. , 2018, The Lancet. Oncology.

[25]  A. Niemierko,et al.  Inter- and Intramouse Heterogeneity of Radiation Response for a Growing Paired Organ , 2008, Radiation research.

[26]  Robert Gentleman,et al.  Statistical Applications in Genetics and Molecular Biology , 2005 .

[27]  Cong Liu,et al.  [Functional Analysis of DNA Damage Repair Factor WDR70 and Its Mutation in Ovarian Cancer]. , 2016, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[28]  T. Puck,et al.  ACTION OF X-RAYS ON MAMMALIAN CELLS , 1956, The Journal of experimental medicine.

[29]  Benjamin Haibe-Kains,et al.  Genomic biomarkers for precision radiation medicine. , 2017, The Lancet. Oncology.

[30]  S. A. Roberts,et al.  Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. , 1993, British Journal of Cancer.

[31]  S. Leivonen,et al.  Hypoxia-activated Smad3-specific Dephosphorylation by PP2A* , 2009, The Journal of Biological Chemistry.

[32]  David J Brenner,et al.  The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. , 2008, Seminars in radiation oncology.

[33]  T. McMillan,et al.  The radiobiology of human cells and tissues. In vitro radiosensitivity. The picture has changed in the 1980s. , 1989, International journal of radiation biology.

[34]  T. McMillan,et al.  The Picture Has Changed in the 1980s , 1989 .

[35]  B. Wouters,et al.  Apoptosis, p53, and tumor cell sensitivity to anticancer agents. , 1999, Cancer research.

[36]  B. Wouters,et al.  Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. , 1997, Radiation research.

[37]  J P Freyer,et al.  Oxygen enhancement ratio as a function of dose and cell cycle phase for radiation-resistant and sensitive CHO cells. , 1991, Radiation research.

[38]  J. Mesirov,et al.  Integrative radiogenomic profiling of squamous cell lung cancer. , 2013, Cancer research.

[39]  B. Fertil,et al.  Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. , 1985, International journal of radiation oncology, biology, physics.

[40]  TIKVAH ALPER,et al.  Role of Oxygen in Modifying the Radiosensitivity of E. Coli B. , 1956, Nature.

[41]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[42]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  T. Kietzmann,et al.  Antioxidant responses and cellular adjustments to oxidative stress , 2015, Redox biology.

[44]  B Palcic,et al.  Reduced oxygen enhancement ratio at low doses of ionizing radiation. , 1984, Radiation research.

[45]  T. Nakano,et al.  Inter-assay precision of clonogenic assays for radiosensitivity in cancer cell line A549 , 2018, Oncotarget.

[46]  P. Tamayo,et al.  A genetic basis for the variation in the vulnerability of cancer to DNA damage , 2016, Nature Communications.

[47]  J. Hendry,et al.  Radiobiology for the Radiologist , 1979, British Journal of Cancer.

[48]  Mechthild Krause,et al.  Radiation oncology in the era of precision medicine , 2016, Nature Reviews Cancer.

[49]  A. Carr,et al.  CRL4Wdr70 regulates H2B monoubiquitination and facilitates Exo1-dependent resection , 2016, Nature Communications.